Dana-farber Cancer Institute
Clinical trials sponsored by Dana-farber Cancer Institute, explained in plain language.
-
Blood test guides throat cancer care, aims to boost survival and cut side effects
Disease control Not yet recruitingThis study tests whether using a blood test that detects HPV DNA can help doctors choose the right treatment intensity for people with HPV-positive throat cancer. About 116 participants with stage I to III cancer will receive treatment tailored to their risk level. The goal is to…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
Can a simple blood test spot hidden cancers? new study aims to find out
Diagnosis Not yet recruitingThis study will test a blood test called the GRAIL Galleri test in 100 adults who have symptoms that might be cancer. The goal is to see if the test can correctly detect different types of cancer and how it compares to standard diagnostic methods. Participants will give a blood s…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Apr 26, 2026 20:01 UTC
-
Can a 'Baby' dose of hormone drugs stop breast cancer before it starts?
Prevention Not yet recruitingThis study compares two low-dose hormone drugs, exemestane and tamoxifen, in 140 post-menopausal women at high risk for breast cancer. The goal is to see which drug causes fewer menopausal side effects while still helping to prevent breast cancer. Participants will take the medic…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Apr 28, 2026 13:02 UTC